^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    ArteraAI Prostate Test

    Company:
    ArteraAI
    Type:
    Laboratory Developed Test
    Details
    Evidence

    News

    27d
    Advancing Precision Oncology with Artificial Intelligence: Ushering in the ArteraAI Prostate Test. (PubMed, Urology)
    No abstract available
    Journal
    |
    ArteraAI Prostate Test
    1m
    Artificial intelligence Steering Testosterone deprivation Treatments in prostate cancer External-beam radiotherapy (ASTuTE) (ANZCTR)
    P=N/A | N=800 | Recruiting | Sponsor: GenesisCare | Not yet recruiting ➔ Recruiting | Initiation date: Dec 2023
    Enrollment open • Trial initiation date
    |
    ArteraAI Prostate Test
    3ms
    ArteraAI Announced as the First-and-Only Predictive Test for Therapy Personalization in the 2024 NCCN Guidelines for Prostate Cancer (Businesswire)
    "ArteraAI...announced today its inclusion in the newly released NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer. The ArteraAI Prostate Test is the only test included for its predictive performance. The test is also the first AI-enabled predictive and prognostic test to be recommended in the guidelines for localized prostate cancer."
    NCCN guideline
    |
    ArteraAI Prostate Test